Rare Disease Report

Bayer Awards More Than $2 Million to Hemophilia Researchers

JULY 11, 2017
James Radke
Today, Bayer announced they have awarded over $2 million to 16 different recipients across 8 countries as part of their Bayer Hemophilia Awards Program (BHAP).
Awardees were announced at the International Society on Thrombosis and Hemostasis (ISTH) 2017 Congress in Berlin, Germany.
Among the recipients are the 4 following American-based researchers:
  • Ai-Hong Zhang, Ph.D., Uniformed Services University of the Health Sciences, Bethesda
  • Bhavya Doshi, M.D., Children's Hospital of Philadelphia
  • Manjunath Goolyam Basavaraj, Ph.D., Children's Hospital of Philadelphia
  • Paris Margaritis, DPhil., Children's Hospital of Philadelphia
In a news release, Ai-Hong Zhang, Ph.D., Uniformed Services University of the Health Sciences, recipient of the Special Project award stated, "My particular research will focus on investigating a novel strategy to promote anti-FVIII inhibitor development, which with continued funding from government and industry supporters such as Bayer, I hope will contribute to improving understanding in the medical community and ultimately benefit the hemophilia community."
The BAHP is now in its 15th year and, to date, the grant program has awarded over $330 million to 280 grants involving researchers from 32 countries. The funding has led to more than 400 publications, poster presentations and other scientific communications by its awardees.
BHAP presents awards to a wide variety of researchers with grants ranging up to $100,000 per year. Categories include in the program include:
Special Project Awards
The Special Project Award is designed to support a wide range of research projects in the field of hemophilia. The award is designed to encourage hypothesis-driven research, and up to 4 are given each year. The maximum grant is $100,000 per year, up to 2 years.
Outcomes Research Awards
This one-off award category is intended to encourage outcomes research in haemophilia and other hereditary bleeding disorders. The funding allows for a project to run for 1 or 2 years, and up to 4 are presented each year. The maximum grant is $25,000 per year.
Early Career Awards
This award will fund salary support and research funds for a junior faculty member who wishes to undertake a mentored basic and/or clinical research project. Up to 4 awards are given each year. Maximum grant is $100,000 per year for 2 years.
Fellowship Project Awards
This award is to facilitate the development of clinical and research expertise in the field of hemophilia for applicants who have completed medical training and have an interest in pursuing a career as a hemophilia clinician. The award will support a mentored physician for 2 years (up to $80,000 per year).
Caregiver Awards
This award recognizes the essential role of caregivers and allied health care professionals in the care of patients with hemophilia. It is designed to support their role by promoting education, training and other activities in the field of hemophilia. Up to 4 awards are given each year. The maximum grant is $25,000 per year.
For more information about BHAP and other grant programs within the rare disease community, click here.
For more research information, be sure to follow Rare Disease Report on Twitter and Facebook.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.